2-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)-5-(2H-tetrazol-5-yl)-1,3,4-thiadiazole

ID: ALA2153600

PubChem CID: 53388366

Max Phase: Preclinical

Molecular Formula: C14H13BrFN7OS

Molecular Weight: 426.28

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Fc1ccc(Br)c(OC2CCN(c3nnc(-c4nn[nH]n4)s3)CC2)c1

Standard InChI:  InChI=1S/C14H13BrFN7OS/c15-10-2-1-8(16)7-11(10)24-9-3-5-23(6-4-9)14-20-19-13(25-14)12-17-21-22-18-12/h1-2,7,9H,3-6H2,(H,17,18,21,22)

Standard InChI Key:  VJYMDTMHJYNRJZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   -0.3665   -8.9106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0445   -9.6269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8657   -9.6291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2821   -8.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8711   -8.2005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0437   -8.1966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1069   -8.9200    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5164   -9.6360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0983  -10.3473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5071  -11.0627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3328  -11.0665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7479  -10.3488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3367   -9.6363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7493   -8.9221    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -1.1915   -8.9105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6761   -8.2431    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4608   -8.4979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4608   -9.3226    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6764   -9.5778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0979   -7.9701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0493   -7.1467    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8174   -6.8460    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3406   -7.4836    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8961   -8.1783    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0915  -11.7751    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  5  6  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 18 19  1  0
  4  7  1  0
  1  2  1  0
 16 17  1  0
  7  8  1  0
  1  6  1  0
  8  9  2  0
 15 16  1  0
 17 18  2  0
 19 15  2  0
  1 15  1  0
 23 24  1  0
  2  3  1  0
  9 10  1  0
 21 22  2  0
  3  4  1  0
 10 11  2  0
  4  5  1  0
 20 21  1  0
 22 23  1  0
 24 20  2  0
 17 20  1  0
 11 12  1  0
 10 25  1  0
M  END

Associated Targets(Human)

FADS2 Tbio Fatty acid desaturase 2 (102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCD Tchem Acyl-CoA desaturase (1011 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FADS1 Tchem Fatty acid desaturase 1 (145 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Fads2 Fatty acid desaturase 2 (39 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (8163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Scd1 Acyl-CoA desaturase 1 (506 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fads1 Fatty acid desaturase 1 (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 426.28Molecular Weight (Monoisotopic): 425.0070AlogP: 2.67#Rotatable Bonds: 4
Polar Surface Area: 92.71Molecular Species: ACIDHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.90CX Basic pKa: CX LogP: 3.32CX LogD: 1.81
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.69Np Likeness Score: -1.78

References

1. Oballa RM, Belair L, Black WC, Bleasby K, Chan CC, Desroches C, Du X, Gordon R, Guay J, Guiral S, Hafey MJ, Hamelin E, Huang Z, Kennedy B, Lachance N, Landry F, Li CS, Mancini J, Normandin D, Pocai A, Powell DA, Ramtohul YK, Skorey K, Sørensen D, Sturkenboom W, Styhler A, Waddleton DM, Wang H, Wong S, Xu L, Zhang L..  (2011)  Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia.,  54  (14): [PMID:21661758] [10.1021/jm200319u]

Source